Non-small-cell lung cancer (NSCLC) represents roughly 85% of lung cancers, with an
incidence that increases yearly across the world. The introduction in clinical practice of …

Lung cancer is a common disease and the leading cause of cancer-related mortality, with
non-small cell lung cancer (NSCLC) accounting for the majority of cases. Following …

Background The surgical treatment of stage I and II non-small cell lung cancer (NSCLC)
continues to evolve in the areas of intraoperative lymph node staging (specifically the issue …

BACKGROUND: Lung cancer has the highest mortality-rate per cancer, with an overall 5-
year survival< 15%. Several non-randomized studies pointed out the high sensitivity of low …

A prognostic impact of immunoglobulin kappa C (IGKC) expression has been described in
cancer. We analysed the influence of B-cell and plasma cell markers, as well as IGKC …

Vimentin is an intermediate filament protein whose expression correlates with increased
metastatic disease, reduced patient survival and poor prognosis across multiple tumor types …

Lung cancer remains the leading cause of cancer mortality in the United States, and the
majority of patients will have non–small cell lung cancer (NSCLC) and will present with …

This study attempts to evaluate the clinicopathologic features of mixed subtype
adenocarcinomas and the prognostic implications of histopathology classifications. Surgical …

Qualitätsindikatoren wurden durch Sens et al. wie folgt definiert:„Ein Indikator ist ein
quantitatives Maß, welches zum Monitoring und zur Bewertung der Qualität wichtiger …

Purpose To date, few large-scale original studies have focused specifically on local
recurrence following curative lung cancer surgery. This review seeks to consolidate and …